The Company continues to explore opportunities to expand its product portfolio. Chippenham -based company Alliance Pharma has reached an agreement with Sinclair Pharma over compensation in connection with the sales shortfall of Kelo-stretch , acquired by Alliance in 2018 . A cash payment of £1m ( £1m ) will be made in two phases, £4m in 2017 and £5m in 2018 , while Alliance Pharma will also relinquish all US rights to Flammacerium . Alliance plans to seek guidance from the US regulatory authority later this year regarding registration of Flammacerium in the country.
Chippenham -based company Alliance Pharma has reached an agreement with Sinclair Pharma over compensation in connection with the sales shortfall of Kelo-stretch , acquired by Alliance in 2018 . A cash payment of £1m ( £1m ) will be made in two phases, £4m in 2017 and £5m in 2018 , while Alliance Pharma will also relinquish all US rights to Flammacerium . Alliance plans to seek guidance from the US regulatory authority later this year regarding registration of Flammacerium in the country.